ENLIGHT-LN
Live / Registered — Registered (as of 16 Apr 2024)
What this means for you
Registered since 16 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97253196
- Registration number
- 7361090
- Mark type
- Stylized text
- Filed
- 04 Feb 2022
- Published for opposition
- 27 Dec 2022
- Registered
- 16 Apr 2024
- Attorney of record
- Matthew R. Wilmot
Goods and services
- Class 042 — Scientific and technological services: Medical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis
Owner
- Aurinia Pharmaceuticals Inc., Victoria, B.C., CA
- Aurinia Pharmaceuticals Inc., Victoria, B.C., CA
- Aurinia Pharmaceuticals Inc., Victoria, B.C., CA
Prosecution history
- 16 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Mar 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Feb 2024 — USE AMENDMENT FILED
- 11 Mar 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 31 Aug 2023 — ASSIGNED TO EXAMINER
- 23 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Aug 2023 — SOU EXTENSION 1 GRANTED
- 21 Aug 2023 — SOU EXTENSION 1 FILED
- 21 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED